The UMass Center for Clinical and Translational Science (UMCCTS) was founded in 2006 to enhance clinical and translational research across the five University of Massachusetts campuses (Amherst, , Dartmouth, , University of Massachusetts Medical School) and our clinical partners, and . With the receipt of an NIH Clinical and Translational Science Award (CTSA) in 2010, and its successful renewal in 2015, the UMCCTS joined a network of 62 NIH-funded centers collaborating to transform the conduct of clinical and translational research across the U.S. Other key partners include our patients and communities, foundations, biotechnology and pharmaceutical companies, and members of the venture capital and philanthropic communities.
UMCCTS goals are: 1) To accelerate the translation of basic discoveries into practical, cost effective solutions that improve human health; and 2) To develop and support the next generation of leaders in clinical and translational research. By supporting investigation that improves the science of translation and that accelerates the translation of UMASS discoveries into products for clinical use, we will improve the health of citizens of the Commonwealth of Massachusetts and the world.
We encourage you to browse through our website to learn more about how the UMCCTS catalyzes clinical and translational research through education and training, pilot funding programs, resources, and services.